Fundraising FoxEnrich Biosystems
Branford, US · Founded 2018 · Delaware corporation · 2 known investors
Find your way into Enrich Biosystems
Sign up to see every warm intro you have to Enrich Biosystems
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Enrich Biosystems team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Enrich Biosystems develops TROVO, a fluidics-free benchtop instrument that compartmentalizes standard culture plates into thousands of hydrogel microwells for high-throughput functional screening, imaging, and live recovery of cells. It serves cell therapy and life sciences researchers working on applications such as CAR-T cell selection, cell line development, and single-cell omics enrichment.
Founders & leadership
Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$8.2M disclosed across 4 rounds · 2022–2025
▶$1.4MraisedNov 2025 · 4 investors · BiotechnologyRule 506(b)
- Daniel WagnerDirector
- Qi ZhaoExecutive Officer, Director
- Christopher McLeodDirector
- Dong WangExecutive Officer, Director
- Jay TeichDirector
- Offering amount
- $1.5M
- Amount sold
- $1.4M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KraisedMay 2024 · 10 investors · BiotechnologyRule 506(b)
- Cynthia GreenDirector
- Qi ZhaoExecutive Officer, Director
- Christopher McLeodDirector
- Jay TeichDirector
- Dong WangExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $750K
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedMay 2024 · 17 investors · BiotechnologyRule 506(b)
- Qi ZhaoExecutive Officer, Director
- Cynthia GreenDirector
- Dong WangExecutive Officer, Director
- Christopher McLeodDirector
- Jay TeichDirector
- Offering amount
- $3.1M
- Amount sold
- $2.2M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.8MraisedJun 2022 · 26 investors · BiotechnologyRule 506(b)
- Cynthia GreenDirector
- Jay TeichDirector
- Christopher McLeodDirector
- Qi ZhaoExecutive Officer, Director
- Dong WangExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $3.8M
- First sale
- May 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Enrich Biosystems.
Frequently asked questions
- What does Enrich Biosystems do?
- Enrich Biosystems develops TROVO, a fluidics-free benchtop instrument that compartmentalizes standard culture plates into thousands of hydrogel microwells for high-throughput functional screening, imaging, and live recovery of cells. It serves cell therapy and life sciences researchers working on applications such as CAR-T cell selection, cell line development, and single-cell omics enrichment.
- Who are Enrich Biosystems's investors?
- Enrich Biosystems's investors include Connecticut Innovations, Elm Street Ventures.
- How much funding has Enrich Biosystems raised?
- Enrich Biosystems has disclosed $8.2M raised across 4 rounds.
- Where is Enrich Biosystems headquartered?
- Enrich Biosystems is headquartered in Branford, US.